Literature DB >> 23633904

Neonatal withdrawal syndrome due to maternal codeine use.

Vrinda Nair1, Amuchou Singh Soraisham, Albert Akierman.   

Abstract

Neonatal withdrawal from maternal drugs and medications is not uncommon. Codeine-containing analgesic preparations given to pregnant mothers for headache have been identified as a cause of neonatal withdrawal syndrome. The present case highlights the importance of obtaining a detailed maternal drug history including prescription and nonprescription drugs, and highlights the need for prenatal counselling for women who are taking narcotic-containing analgesics.

Entities:  

Keywords:  Codeine; Newborn; Tylenol; Withdrawal syndrome

Year:  2012        PMID： 23633904      PMCID： PMC3381925          DOI： 10.1093/pch/17.5.e40

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN： 1205-7088            Impact factor:   2.253


  11 in total

1.  Assessment and treatment of abstinence in the infant of the drug-dependent mother.

Authors:  L P Finnegan; R E Kron; J F Connaughton; J P Emich
Journal:  Int J Clin Pharmacol Biopharm       Date:  1975-07

2.  Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother.

Authors:  Gideon Koren; James Cairns; David Chitayat; Andrea Gaedigk; Steven J Leeder
Journal:  Lancet       Date:  2006-08-19       Impact factor: 79.321

3.  Codeine and morphine pathway.

Authors:  Caroline F Thorn; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2009-07       Impact factor: 2.089

4.  Neonatal drug withdrawal. American Academy of Pediatrics Committee on Drugs.

Authors: 
Journal:  Pediatrics       Date:  1998-06       Impact factor: 7.124

5.  Neonatal codeine withdrawal in infants of nonaddicted mothers.

Authors:  H H Mangurten; R Benawra
Journal:  Pediatrics       Date:  1980-01       Impact factor: 7.124

6.  Neonatal abstinence syndrome due to codeine.

Authors:  K Khan; J Chang
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-01       Impact factor: 5.747

7.  Infants and young children metabolise codeine to morphine. A study after single and repeated rectal administration.

Authors:  H Quiding; G L Olsson; L O Boreus; U Bondesson
Journal:  Br J Clin Pharmacol       Date:  1992-01       Impact factor: 4.335

8.  Relationship of maternal substance abuse to subsequent sudden infant death syndrome in offspring.

Authors:  S R Kandall; J Gaines; L Habel; G Davidson; D Jessop
Journal:  J Pediatr       Date:  1993-07       Impact factor: 4.406

9.  Adverse neurodevelopmental outcome of infants exposed to opiate in-utero.

Authors:  Rod W Hunt; Dimitra Tzioumi; Edith Collins; Heather E Jeffery
Journal:  Early Hum Dev       Date:  2007-08-28       Impact factor: 2.079

10.  Differential foetal development of the O- and N-demethylation of codeine and dextromethorphan in man.

Authors:  M G Ladona; B Lindström; C Thyr; P Dun-Ren; A Rane
Journal:  Br J Clin Pharmacol       Date:  1991-09       Impact factor: 4.335
View more
  2 in total

Review 1.  Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects.

Authors:  Irma Convertino; Alice Capogrosso Sansone; Alessandra Marino; Maria T Galiulo; Stefania Mantarro; Luca Antonioli; Matteo Fornai; Corrado Blandizzi; Marco Tuccori
Journal:  Drug Saf       Date:  2016-10       Impact factor: 5.606

2.  Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study.

Authors:  Rishi J Desai; Krista F Huybrechts; Sonia Hernandez-Diaz; Helen Mogun; Elisabetta Patorno; Karol Kaltenbach; Leslie S Kerzner; Brian T Bateman
Journal:  BMJ       Date:  2015-05-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.